X-trodes Closes $4.5M Seed Funding


X-trodes, a Tel Aviv, Israel-based bio-convergence company that developed wearable technology for advanced electrophysiological measurement and analytics, raised $4.5m in seed funding.

The round was led by Japan Israel High Tech Ventures (Chartered Group), Welltech. and Jeremy Coller.

Led by Ziv Peremen, co-founder and CEO, X-trodes is a bio-convergence company and the developer of the world’s first scalable wireless┬áSmart Skin- a wearable technology for advanced electrophysiological monitoring and analytics, that can be used by patients in their natural environment.

The two first products that X-trodes brings to market are:

  1. Medical-grade sleep monitoring- a wireless system for sleep monitoring, especially for neurological and psychiatric disorders.┬á X-trodes single patch for multi-modality measurement, retrieves meaningful insights and diagnostics from patients’ own bed, in their natural environment.
  2. Muscle recovery┬á– A flexible wearable system that prevents muscle injuries and accelerates recovery by monitoring electrophysiology function in dynamic environments and analysing every muscle with wireless AI-driven insights.

The company has 12 employees.